Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral)), Application (Biomedical, Protein Production), End User - Global Forecast to 2021
The global transfection reagents and equipment market is expected to reach USD 1.02 billion by 2021 from USD 715.4 million in 2016, at a CAGR of 7.5% during the forecast period 2016 to 2021.
Over the years, the transfection reagents and equipment market has witnessed various technological advancements in equipment as well as reagents to address the requirements of researchers and biotechnology & biopharmaceutical companies. These advancements have led to the development of transfection instruments that are of higher efficiency. It has also resulted in efficient quantitative and qualitative transfection in a wide range of cells, including the hard-to-transfect cells.
In 2016, the reagents segment is expected to account for the largest share of the market, by product. The biochemical method segment is expected to account for the largest share of the market, by method. The academic & research institutes segment is expected to account for the largest share of the market, by end user. The biomedical research segment is expected to account for the largest share of the market, by application.
In 2016, North America is expected to account for the largest share of the global transfection reagents and equipment market, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period, with emphasis on India, China, and Japan. Growth in these countries can be attributed to the increase in research activities conducted in these regions, rapid expansion of the biotechnology and pharmaceutical industry, government as well as private sector support, increase in cancer incidence, and favorable regulatory framework.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopted various strategies such as agreements, collaborations and partnerships, new product launches, expansions, and acquisitions to increase their presence and establish a strong foothold in the global market.
In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the transfection reagents and equipment market
Research Coverage
The report provides a picture of the transfection reagents and equipment market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by product, method, end user, application, and regions. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, product pipeline, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms, to garner a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
Over the years, the transfection reagents and equipment market has witnessed various technological advancements in equipment as well as reagents to address the requirements of researchers and biotechnology & biopharmaceutical companies. These advancements have led to the development of transfection instruments that are of higher efficiency. It has also resulted in efficient quantitative and qualitative transfection in a wide range of cells, including the hard-to-transfect cells.
In 2016, the reagents segment is expected to account for the largest share of the market, by product. The biochemical method segment is expected to account for the largest share of the market, by method. The academic & research institutes segment is expected to account for the largest share of the market, by end user. The biomedical research segment is expected to account for the largest share of the market, by application.
In 2016, North America is expected to account for the largest share of the global transfection reagents and equipment market, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period, with emphasis on India, China, and Japan. Growth in these countries can be attributed to the increase in research activities conducted in these regions, rapid expansion of the biotechnology and pharmaceutical industry, government as well as private sector support, increase in cancer incidence, and favorable regulatory framework.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopted various strategies such as agreements, collaborations and partnerships, new product launches, expansions, and acquisitions to increase their presence and establish a strong foothold in the global market.
In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the transfection reagents and equipment market
- By Company Type: Tier 1: 56%, Tier 2: 34%, and Tier 3: 10%
- By Designation: Director Level: 28%, C-level: 19%, and Others: 53%
- By Region: North America: 27%, Europe: 27%, APAC: 30%, and RoW: 16%
Research Coverage
The report provides a picture of the transfection reagents and equipment market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by product, method, end user, application, and regions. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, product pipeline, and key market strategies.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms, to garner a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the transfection reagents and equipment market. The report analyzes the transfection reagents and equipment market, by product, method, end user, application, and region
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the transfection reagents and equipment market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transfection methods across regions
- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the transfection technologies market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transfection reagents and equipment market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH METHODOLOGY STEPS
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.2.2.1 Key data from primary sources
2.2.2.2 Key insights from primary sources
2.2.2.3 Key industry insights
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.3.1 MARKET FORECAST METHODOLOGY
2.4 MARKET DATA VALIDATION AND TRIANGULATION
2.5 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL TRANSFECTION TECHNOLOGIES MARKET
4.2 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION & REGION
4.3 GEOGRAPHIC SNAPSHOT: TRANSFECTION TECHNOLOGIES MARKET
4.4 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2016 VS. 2021)
4.5 TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2016 VS. 2021 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Technological advancements in transfection technology
5.2.1.1.1 CRISPR-Cas9
5.2.1.1.2 CAR-T
5.2.1.1.3 Three Dimension (3D) transfection technology
5.2.1.2 Global alliances among leading research institutes to trigger drug discovery
5.2.1.3 Increase in R&D spending and research activities by pharmaceutical and biotech companies
5.2.1.4 Growing research activities in cell science
5.2.1.5 Increase in demand for synthetic genes
5.2.1.6 Rising incidence of cancer worldwide
5.2.2 RESTRAINTS
5.2.2.1 Selective effectiveness of transfection reagents
5.2.2.2 Home brew reagents restrict sale of commercial kits
5.2.2.3 High cost of transfection reagents
5.2.3 OPPORTUNITIES
5.2.3.1 Large-scale transfections
5.2.3.2 High-growth opportunities in asian market
5.2.3.2.1 India
5.2.3.2.2 China
5.2.4 CHALLENGES
5.2.4.1 Transfection in hard-to-transfect cells
5.2.4.2 Cytotoxicity in transfection - a major concern
6 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 REAGENTS
6.3 EQUIPMENT
7 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD
7.1 INTRODUCTION
7.2 BIOCHEMICAL METHODS
7.2.1 LIPOFECTION
7.2.1.1 Advantages
7.2.1.2 Disadvantages
7.2.2 CALCIUM PHOSPHATE
7.2.2.1 Advantages
7.2.2.2 Disadvantages
7.2.3 DEAE-DEXTRAN
7.2.3.1 Advantages
7.2.3.2 Disadvantages
7.2.4 DENDRIMERS
7.2.4.1 Advantages
7.2.4.2 Disadvantages
7.3 PHYSICAL
7.3.1 ELECTROPORATION
7.3.1.1 Advantages
7.3.1.2 Disadvantages
7.3.2 NUCLEOFECTION
7.3.2.1 Advantages
7.3.2.2 Disadvantages
7.3.3 OTHER METHODS
7.3.3.1 Sonoporation
7.3.3.2 Genegun
7.3.3.2.1 Advantages
7.3.3.2.2 Disadvantages
7.3.3.3 Magnetofection
7.3.3.3.1 Advantages
7.3.3.3.2 Disadvantages
7.3.3.4 Optoinjection
7.3.3.4.1 Advantages
7.3.3.4.2 Disadvantages
7.4 VIRAL METHODS
7.4.1 ADENOVIRUSES
7.4.2 RETROVIRUSES
7.4.3 ADENOASSOCIATED VIRUSES (AAV)
8 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 BIOMEDICAL RESEARCH
8.2.1 GENE EXPRESSION STUDIES
8.2.2 CANCER RESEARCH
8.2.3 TRANSGENIC MODELS
8.3 PROTEIN PRODUCTION
8.4 THERAPEUTIC DELIVERY
9 TRANSFECTION TECHNOLOGIES MARKET, BY END USER
9.1 INTRODUCTION
9.2 ACADEMICS & RESEARCH INSTITUTES
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10 TRANSFECTION TECHNOLOGIES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.1.1 Increase in bio-based drug research
10.2.1.2 Growing demand for protein-based therapeutics triggers the growth of U.S. market
10.2.1.3 Increasing funding for biotechnology and for development of protein-based biologics
10.2.1.4 Conferences/meetings/symposiums/workshops
10.2.2 CANADA
10.2.2.1 Government support for development of protein drugs is expected to drive the market for transfection technologies
10.2.2.2 Increasing investments by the canadian government on regenerative medicine to drive market growth
10.2.2.3 Increasing funding for genome engineering in Canada likely to boost transfection technologies market
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Growing biotech industry and research funding in germany
10.3.1.2 Collaboration among bio-pharmaceutical and biotechnology companies for the development of new vaccines is likely to drive the market growth
10.3.1.3 Conferences and meetings/workshops in Germany
10.3.1.4 Availability of funding for life science research in Germany
10.3.2 U.K.
10.3.2.1 10,000 genome project initiative in U.K.
10.3.2.2 Initiative to increase R&D investments in U.K.
10.3.3 REST OF EUROPE
10.3.3.1 Growing biotechnology and pharma industry in Italy
10.3.3.2 Focus on research in Spain
10.3.3.3 Investments and funding for life sciences to drive the transfection technologies market
10.3.3.4 Growing research investments in Sweden & Denmark
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.1.1 Rise in biomedical research in Japan
10.4.2 CHINA
10.4.2.1 Chinese government initiatives for life sciences R&D likely to boost the market
10.4.2.2 Industry initiative to boost transfection technology market in China
10.4.3 INDIA
10.4.3.1 Booming pharmaceutical and biotechnology industries
10.4.3.2 Development of bio-clusters in India
10.4.4 REST OF ASIA-PACIFIC
10.4.4.1 Federal collaborations in Australia
10.4.4.2 Funding for research on proteomics and genomics in Australia
10.4.4.3 Rising pharmaceutical and biotechnology R&D activities in South Korea
10.4.4.4 Government support for strong academic and commercial R&D activities in Taiwan
10.4.4.5 Genome Asia 100k initative
10.5 REST OF THE WORD (ROW)
10.5.1 LATIN AMERICA
10.5.1.1 Increasing investment in Brazil and Mexico
10.5.1.2 Brazil: investment in research and innovation centers and conferences & workshops
10.5.2 MIDDLE EAST & AFRICA
10.5.2.1 Increasing focus of major pharmaceutical, biopharmaceutical, and biotechnology firms in Saudi Arabia and the United Arab Emirates (UAE) and African regions
10.5.2.2 Genetic testing and genomic analysis in the Middle East
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.2.1 INTRODUCTION
11.2.2 THERMO FISHER SCIENTIFIC INC.
11.2.3 PROMEGA CORPORATION
11.2.4 F. HOFFMANN-LA ROCHE LTD
11.2.5 QIAGEN N.V.
11.3 COMPETITIVE SITUATION AND TRENDS
11.4 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
11.5 NEW PRODUCT LAUNCHES
11.6 EXPANSIONS
11.7 ACQUISITIONS
11.8 OTHER STRATEGIES
12 COMPANY PROFILES
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 THERMO FISHER SCIENTIFIC INC. (LIFE TECHNOLOGIES)
12.2 PROMEGA CORPORATION
12.3 QIAGEN N.V.
12.4 F. HOFFMANN-LA ROCHE LTD
12.5 BIO–RAD LABORATORIES, INC.
12.6 MAXCYTE, INC.
12.7 LONZA GROUP LTD.
12.8 MERCK KGAA
12.9 POLYPLUS-TRANSFECTION SA
12.10 MIRUS BIO LLC.
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 OTHER DEVELOPMENTS
13.2.1 MAXCYTE INC.
13.2.2 LONZA GROUP LTD.
13.2.3 QIAGEN N.V.
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH METHODOLOGY STEPS
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.2.2.1 Key data from primary sources
2.2.2.2 Key insights from primary sources
2.2.2.3 Key industry insights
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.3.1 MARKET FORECAST METHODOLOGY
2.4 MARKET DATA VALIDATION AND TRIANGULATION
2.5 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL TRANSFECTION TECHNOLOGIES MARKET
4.2 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION & REGION
4.3 GEOGRAPHIC SNAPSHOT: TRANSFECTION TECHNOLOGIES MARKET
4.4 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2016 VS. 2021)
4.5 TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2016 VS. 2021 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Technological advancements in transfection technology
5.2.1.1.1 CRISPR-Cas9
5.2.1.1.2 CAR-T
5.2.1.1.3 Three Dimension (3D) transfection technology
5.2.1.2 Global alliances among leading research institutes to trigger drug discovery
5.2.1.3 Increase in R&D spending and research activities by pharmaceutical and biotech companies
5.2.1.4 Growing research activities in cell science
5.2.1.5 Increase in demand for synthetic genes
5.2.1.6 Rising incidence of cancer worldwide
5.2.2 RESTRAINTS
5.2.2.1 Selective effectiveness of transfection reagents
5.2.2.2 Home brew reagents restrict sale of commercial kits
5.2.2.3 High cost of transfection reagents
5.2.3 OPPORTUNITIES
5.2.3.1 Large-scale transfections
5.2.3.2 High-growth opportunities in asian market
5.2.3.2.1 India
5.2.3.2.2 China
5.2.4 CHALLENGES
5.2.4.1 Transfection in hard-to-transfect cells
5.2.4.2 Cytotoxicity in transfection - a major concern
6 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 REAGENTS
6.3 EQUIPMENT
7 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD
7.1 INTRODUCTION
7.2 BIOCHEMICAL METHODS
7.2.1 LIPOFECTION
7.2.1.1 Advantages
7.2.1.2 Disadvantages
7.2.2 CALCIUM PHOSPHATE
7.2.2.1 Advantages
7.2.2.2 Disadvantages
7.2.3 DEAE-DEXTRAN
7.2.3.1 Advantages
7.2.3.2 Disadvantages
7.2.4 DENDRIMERS
7.2.4.1 Advantages
7.2.4.2 Disadvantages
7.3 PHYSICAL
7.3.1 ELECTROPORATION
7.3.1.1 Advantages
7.3.1.2 Disadvantages
7.3.2 NUCLEOFECTION
7.3.2.1 Advantages
7.3.2.2 Disadvantages
7.3.3 OTHER METHODS
7.3.3.1 Sonoporation
7.3.3.2 Genegun
7.3.3.2.1 Advantages
7.3.3.2.2 Disadvantages
7.3.3.3 Magnetofection
7.3.3.3.1 Advantages
7.3.3.3.2 Disadvantages
7.3.3.4 Optoinjection
7.3.3.4.1 Advantages
7.3.3.4.2 Disadvantages
7.4 VIRAL METHODS
7.4.1 ADENOVIRUSES
7.4.2 RETROVIRUSES
7.4.3 ADENOASSOCIATED VIRUSES (AAV)
8 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 BIOMEDICAL RESEARCH
8.2.1 GENE EXPRESSION STUDIES
8.2.2 CANCER RESEARCH
8.2.3 TRANSGENIC MODELS
8.3 PROTEIN PRODUCTION
8.4 THERAPEUTIC DELIVERY
9 TRANSFECTION TECHNOLOGIES MARKET, BY END USER
9.1 INTRODUCTION
9.2 ACADEMICS & RESEARCH INSTITUTES
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10 TRANSFECTION TECHNOLOGIES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.1.1 Increase in bio-based drug research
10.2.1.2 Growing demand for protein-based therapeutics triggers the growth of U.S. market
10.2.1.3 Increasing funding for biotechnology and for development of protein-based biologics
10.2.1.4 Conferences/meetings/symposiums/workshops
10.2.2 CANADA
10.2.2.1 Government support for development of protein drugs is expected to drive the market for transfection technologies
10.2.2.2 Increasing investments by the canadian government on regenerative medicine to drive market growth
10.2.2.3 Increasing funding for genome engineering in Canada likely to boost transfection technologies market
10.3 EUROPE
10.3.1 GERMANY
10.3.1.1 Growing biotech industry and research funding in germany
10.3.1.2 Collaboration among bio-pharmaceutical and biotechnology companies for the development of new vaccines is likely to drive the market growth
10.3.1.3 Conferences and meetings/workshops in Germany
10.3.1.4 Availability of funding for life science research in Germany
10.3.2 U.K.
10.3.2.1 10,000 genome project initiative in U.K.
10.3.2.2 Initiative to increase R&D investments in U.K.
10.3.3 REST OF EUROPE
10.3.3.1 Growing biotechnology and pharma industry in Italy
10.3.3.2 Focus on research in Spain
10.3.3.3 Investments and funding for life sciences to drive the transfection technologies market
10.3.3.4 Growing research investments in Sweden & Denmark
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.1.1 Rise in biomedical research in Japan
10.4.2 CHINA
10.4.2.1 Chinese government initiatives for life sciences R&D likely to boost the market
10.4.2.2 Industry initiative to boost transfection technology market in China
10.4.3 INDIA
10.4.3.1 Booming pharmaceutical and biotechnology industries
10.4.3.2 Development of bio-clusters in India
10.4.4 REST OF ASIA-PACIFIC
10.4.4.1 Federal collaborations in Australia
10.4.4.2 Funding for research on proteomics and genomics in Australia
10.4.4.3 Rising pharmaceutical and biotechnology R&D activities in South Korea
10.4.4.4 Government support for strong academic and commercial R&D activities in Taiwan
10.4.4.5 Genome Asia 100k initative
10.5 REST OF THE WORD (ROW)
10.5.1 LATIN AMERICA
10.5.1.1 Increasing investment in Brazil and Mexico
10.5.1.2 Brazil: investment in research and innovation centers and conferences & workshops
10.5.2 MIDDLE EAST & AFRICA
10.5.2.1 Increasing focus of major pharmaceutical, biopharmaceutical, and biotechnology firms in Saudi Arabia and the United Arab Emirates (UAE) and African regions
10.5.2.2 Genetic testing and genomic analysis in the Middle East
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 MARKET SHARE ANALYSIS
11.2.1 INTRODUCTION
11.2.2 THERMO FISHER SCIENTIFIC INC.
11.2.3 PROMEGA CORPORATION
11.2.4 F. HOFFMANN-LA ROCHE LTD
11.2.5 QIAGEN N.V.
11.3 COMPETITIVE SITUATION AND TRENDS
11.4 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
11.5 NEW PRODUCT LAUNCHES
11.6 EXPANSIONS
11.7 ACQUISITIONS
11.8 OTHER STRATEGIES
12 COMPANY PROFILES
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 THERMO FISHER SCIENTIFIC INC. (LIFE TECHNOLOGIES)
12.2 PROMEGA CORPORATION
12.3 QIAGEN N.V.
12.4 F. HOFFMANN-LA ROCHE LTD
12.5 BIO–RAD LABORATORIES, INC.
12.6 MAXCYTE, INC.
12.7 LONZA GROUP LTD.
12.8 MERCK KGAA
12.9 POLYPLUS-TRANSFECTION SA
12.10 MIRUS BIO LLC.
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 OTHER DEVELOPMENTS
13.2.1 MAXCYTE INC.
13.2.2 LONZA GROUP LTD.
13.2.3 QIAGEN N.V.
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.5 AVAILABLE CUSTOMIZATIONS
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 INDICATIVE LIST OF CELL-BASED RESEARCH STUDIES
Table 2 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 3 TRANSFECTION REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 4 TRANSFECTION INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 5 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 6 BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 7 BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 8 LIPOFECTION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 9 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CALCIUM PHOSPHATE METHOD, BY REGION, 2014–2021 (USD MILLION)
Table 10 DEAE-DEXTRAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 DENDRIMER TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 13 PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 ELECTROPORATION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 NUCLEOFECTION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 16 OTHER PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 17 VIRAL SYSTEMS
Table 18 VIRAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 20 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
Table 21 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY REGION, 2014-2021 (USD MILLION)
Table 22 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR GENE EXPRESSION STUDIES, BY REGION, 2014-2021 (USD MILLION)
Table 23 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CANCER RESEARCH, BY REGION, 2014-2021 (USD MILLION)
Table 24 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR TRANSGENIC MODELS, BY REGION, 2014-2021 (USD MILLION)
Table 25 INDICATIVE LIST OF FEW RECOMBINANT PROTEINS, VACCINES FROM DIFFERENT CELL TYPES
Table 26 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PROTEIN PRODUCTION, BY REGION, 2014-2021 (USD MILLION)
Table 27 INDICATIVE LIST OF DRUG DELIVERY SYSTEMS FOR VARIOUS DISEASE CONDITIONS
Table 28 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR THERAPEUTIC DELIVERY, BY REGION, 2014-2021 (USD MILLION)
Table 29 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 30 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2014–2021 (USD MILLION)
Table 31 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2014–2021 (USD MILLION)
Table 32 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 33 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 34 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table 35 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
Table 36 NORTH AMERICA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 37 NORTH AMERICA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 38 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 39 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
Table 40 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 41 LIST OF MONOCLONAL ANTIBODIES APPROVED BY FDA IN 2015
Table 42 INDICATIVE LIST OF UPCOMING EVENTS IN THE U.S.
Table 43 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table 44 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
Table 45 U.S.: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 46 U.S.: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 47 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 48 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
Table 49 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 50 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table 51 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
Table 52 CANADA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 53 CANADA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 54 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 55 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
Table 56 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 57 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 58 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 59 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 60 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 61 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 62 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 63 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 64 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 65 INDICATIVE LIST OF UPCOMING EVENTS IN GERMANY
Table 66 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 67 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 68 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 69 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 70 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 71 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 72 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 73 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 74 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 75 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE BIOCHEMICAL METHOD, BY TYPE 2014–2021 (USD MILLION)
Table 76 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE PHYSICAL METHOD, BY TYPE 2014–2021 (USD MILLION)
Table 77 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 78 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 79 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 80 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 81 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 82 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 83 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 84 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 85 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 86 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 87 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 88 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 89 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 90 ASIA-PACIFIC: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 91 ASIA-PACIFIC: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 92 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 93 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 94 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 95 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 96 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 97 JAPAN: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 98 JAPAN: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 99 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 100 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 101 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 102 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 103 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 104 CHINA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 105 CHINA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 106 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 107 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 108 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 109 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 110 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 111 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 112 INDIA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 113 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 114 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 115 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 116 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 117 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 118 REST OF ASIA-PACIFIC: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 119 REST OF ASIA-PACIFIC: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 120 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 121 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 122 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 123 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 124 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 125 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 126 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 127 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 128 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
Table 129 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 130 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 2013–2016
Table 131 NEW PRODUCT LAUNCHES, 2013-2016
Table 132 EXPANSIONS, 2013–2016
Table 133 ACQUISITIONS, 2013–2016
Table 134 OTHER STRATEGIES, 2013–2016
Table 1 INDICATIVE LIST OF CELL-BASED RESEARCH STUDIES
Table 2 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 3 TRANSFECTION REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 4 TRANSFECTION INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 5 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 6 BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 7 BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 8 LIPOFECTION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 9 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CALCIUM PHOSPHATE METHOD, BY REGION, 2014–2021 (USD MILLION)
Table 10 DEAE-DEXTRAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 DENDRIMER TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 13 PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 14 ELECTROPORATION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 NUCLEOFECTION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 16 OTHER PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 17 VIRAL SYSTEMS
Table 18 VIRAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 20 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
Table 21 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY REGION, 2014-2021 (USD MILLION)
Table 22 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR GENE EXPRESSION STUDIES, BY REGION, 2014-2021 (USD MILLION)
Table 23 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CANCER RESEARCH, BY REGION, 2014-2021 (USD MILLION)
Table 24 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR TRANSGENIC MODELS, BY REGION, 2014-2021 (USD MILLION)
Table 25 INDICATIVE LIST OF FEW RECOMBINANT PROTEINS, VACCINES FROM DIFFERENT CELL TYPES
Table 26 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PROTEIN PRODUCTION, BY REGION, 2014-2021 (USD MILLION)
Table 27 INDICATIVE LIST OF DRUG DELIVERY SYSTEMS FOR VARIOUS DISEASE CONDITIONS
Table 28 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR THERAPEUTIC DELIVERY, BY REGION, 2014-2021 (USD MILLION)
Table 29 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 30 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2014–2021 (USD MILLION)
Table 31 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2014–2021 (USD MILLION)
Table 32 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
Table 33 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 34 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table 35 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
Table 36 NORTH AMERICA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 37 NORTH AMERICA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 38 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 39 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
Table 40 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 41 LIST OF MONOCLONAL ANTIBODIES APPROVED BY FDA IN 2015
Table 42 INDICATIVE LIST OF UPCOMING EVENTS IN THE U.S.
Table 43 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table 44 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
Table 45 U.S.: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 46 U.S.: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 47 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 48 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
Table 49 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 50 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
Table 51 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION)
Table 52 CANADA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 53 CANADA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
Table 54 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 55 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
Table 56 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 57 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 58 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 59 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 60 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 61 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 62 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 63 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 64 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 65 INDICATIVE LIST OF UPCOMING EVENTS IN GERMANY
Table 66 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 67 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 68 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 69 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 70 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 71 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 72 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 73 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 74 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 75 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE BIOCHEMICAL METHOD, BY TYPE 2014–2021 (USD MILLION)
Table 76 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE PHYSICAL METHOD, BY TYPE 2014–2021 (USD MILLION)
Table 77 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 78 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 79 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 80 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 81 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 82 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 83 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 84 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 85 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 86 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 87 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 88 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 89 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 90 ASIA-PACIFIC: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 91 ASIA-PACIFIC: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 92 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 93 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 94 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 95 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 96 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 97 JAPAN: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 98 JAPAN: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 99 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 100 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 101 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 102 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 103 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 104 CHINA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 105 CHINA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 106 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 107 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 108 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 109 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 110 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 111 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 112 INDIA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 113 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 114 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 115 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 116 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 117 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 118 REST OF ASIA-PACIFIC: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 119 REST OF ASIA-PACIFIC: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 120 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 121 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION)
Table 122 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 123 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 124 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION)
Table 125 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 126 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION)
Table 127 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
Table 128 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION)
Table 129 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
Table 130 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 2013–2016
Table 131 NEW PRODUCT LAUNCHES, 2013-2016
Table 132 EXPANSIONS, 2013–2016
Table 133 ACQUISITIONS, 2013–2016
Table 134 OTHER STRATEGIES, 2013–2016
LIST OF FIGURES
Figure 1 RESEARCH METHODOLOGY: GLOBAL TRANSFECTION TECHNOLOGIES MARKET
Figure 2 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 SAMPLING FRAME: PRIMARY RESEARCH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 6 RESEARCH DESIGN: GLOBAL TRANSFECTION TECHNOLOGIES MARKET
Figure 7 DATA TRIANGULATION METHODOLOGY
Figure 8 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD (2016)
Figure 9 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2016–2021)
Figure 10 TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2016 VS. 2021
Figure 11 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
Figure 12 ASIA-PACIFIC IS PROJECTED TO WITNESS THE HIGHEST GROWTH IN THE TRANSFECTION TECHNOLOGIES MARKET DURING THE FORECAST PERIOD
Figure 13 NORTH AMERICA IS ESTIMATED TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
Figure 14 BIOMEDICAL RESEARCH SEGMENT TO DOMINATE THE TRANSFECTION TECHNOLOGIES MARKET IN 2016
Figure 15 ASIA-PACIFIC IS PROJECTED TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 16 REAGENTS SEGMENT IS PROJECTED TO ACCOUNT FOR THE LARGEST SHARE THROUGH 2021
Figure 17 ACADEMIC & RESEARCH INSTITUTES SEGMENT IS EXPECTED TO DOMINATE THE MARKET THROUGH 2021
Figure 18 MARKET DYNAMICS
Figure 19 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2016–2021 (USD MILLION)
Figure 20 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2016 VS. 2021 (USD MILLION)
Figure 21 TRANSFECTION TECHNOLOGIES MARKET: BY APPLICATION
Figure 22 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
Figure 23 TRANSFECTION TECHNOLOGIES MARKET: BY REGION, 2016-2021
Figure 24 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
Figure 25 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
Figure 26 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
Figure 27 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, ARE THE MAJOR STRATEGIES ADOPTED BY THE KEY PLAYERS, 2013–2016
Figure 28 GLOBAL TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2015
Figure 29 AGREEMENTS,COLLABORATIONS, AND PARTNERSHIPS: KEY STRATEGY ADOPTED BY PLAYERS (2013–2016)
Figure 30 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS, BY COMPANY (2013–2016)
Figure 31 NEW PRODUCT LAUNCHES, BY COMPANY (2013–2016)
Figure 32 EXPANSIONS, BY COMPANY (2013–2016)
Figure 33 ACQUISITION, BY COMPANY (2013–2016)
Figure 34 OTHER STRATEGIES, BY COMPANY (2013–2016)
Figure 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
Figure 36 PROMEGA CORPORATION: COMPANY SNAPSHOT
Figure 37 QIAGEN N.V.: COMPANY SNAPSHOT
Figure 38 ROCHE: COMPANY SNAPSHOT
Figure 39 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
Figure 40 MAXCYTE INC.: COMPANY SNAPSHOT
Figure 41 LONZA GROUP: COMPANY SNAPSHOT
Figure 42 MERCK KGAA: COMPANY SNAPSHOT
Figure 43 SIGMA ALDRICH CORPORATION: COMPANY SNAPSHOT
Figure 1 RESEARCH METHODOLOGY: GLOBAL TRANSFECTION TECHNOLOGIES MARKET
Figure 2 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 3 SAMPLING FRAME: PRIMARY RESEARCH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 6 RESEARCH DESIGN: GLOBAL TRANSFECTION TECHNOLOGIES MARKET
Figure 7 DATA TRIANGULATION METHODOLOGY
Figure 8 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD (2016)
Figure 9 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2016–2021)
Figure 10 TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2016 VS. 2021
Figure 11 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2016 VS. 2021 (USD MILLION)
Figure 12 ASIA-PACIFIC IS PROJECTED TO WITNESS THE HIGHEST GROWTH IN THE TRANSFECTION TECHNOLOGIES MARKET DURING THE FORECAST PERIOD
Figure 13 NORTH AMERICA IS ESTIMATED TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
Figure 14 BIOMEDICAL RESEARCH SEGMENT TO DOMINATE THE TRANSFECTION TECHNOLOGIES MARKET IN 2016
Figure 15 ASIA-PACIFIC IS PROJECTED TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 16 REAGENTS SEGMENT IS PROJECTED TO ACCOUNT FOR THE LARGEST SHARE THROUGH 2021
Figure 17 ACADEMIC & RESEARCH INSTITUTES SEGMENT IS EXPECTED TO DOMINATE THE MARKET THROUGH 2021
Figure 18 MARKET DYNAMICS
Figure 19 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2016–2021 (USD MILLION)
Figure 20 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2016 VS. 2021 (USD MILLION)
Figure 21 TRANSFECTION TECHNOLOGIES MARKET: BY APPLICATION
Figure 22 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2016 VS. 2021 (USD MILLION)
Figure 23 TRANSFECTION TECHNOLOGIES MARKET: BY REGION, 2016-2021
Figure 24 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
Figure 25 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
Figure 26 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT
Figure 27 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, ARE THE MAJOR STRATEGIES ADOPTED BY THE KEY PLAYERS, 2013–2016
Figure 28 GLOBAL TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2015
Figure 29 AGREEMENTS,COLLABORATIONS, AND PARTNERSHIPS: KEY STRATEGY ADOPTED BY PLAYERS (2013–2016)
Figure 30 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS, BY COMPANY (2013–2016)
Figure 31 NEW PRODUCT LAUNCHES, BY COMPANY (2013–2016)
Figure 32 EXPANSIONS, BY COMPANY (2013–2016)
Figure 33 ACQUISITION, BY COMPANY (2013–2016)
Figure 34 OTHER STRATEGIES, BY COMPANY (2013–2016)
Figure 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
Figure 36 PROMEGA CORPORATION: COMPANY SNAPSHOT
Figure 37 QIAGEN N.V.: COMPANY SNAPSHOT
Figure 38 ROCHE: COMPANY SNAPSHOT
Figure 39 BIO-RAD LABORATORIES: COMPANY SNAPSHOT
Figure 40 MAXCYTE INC.: COMPANY SNAPSHOT
Figure 41 LONZA GROUP: COMPANY SNAPSHOT
Figure 42 MERCK KGAA: COMPANY SNAPSHOT
Figure 43 SIGMA ALDRICH CORPORATION: COMPANY SNAPSHOT
